Theravance reports positive data from Anoro Ellipta’s third lung function trial in COPD

Theravance has reported positive results from a third lung function trial of Anoro Ellipta (umeclidinium /vilanterol, UMEC/VI) with the LAMA tiotropium, administered in the HandiHaler inhaler, in patients with chronic obstructive pulmonary disease (C…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news